Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for ovarian cancer.

Adam N Rosenthal1, Usha Menon, Ian J Jacobs

  • 1Institute for Women's Health, University College London, Elizabeth Garrett Anderson Hospital, London, UK. adam.rosenthal@ucl.ac.uk

Clinical Obstetrics and Gynecology
|August 4, 2006
PubMed
Summary

Ovarian cancer screening efficacy is unproven. Ongoing trials use advanced ultrasound and tumor markers to assess mortality impact, while serum proteomics requires further validation for biomarker discovery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of lynch syndrome endometrial surveillance in the Netherlands.

EClinicalMedicine·2026
Same author

Transforming endometrial cancer diagnosis: the case for molecular triage in abnormal uterine and post-menopausal bleeding.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026
Same author

Personalized Primary and Secondary Prevention in Ovarian Cancer.

JAMA oncology·2025
Same author

Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS.

EBioMedicine·2025
Same author

Natural Killer Cell Dysfunction in Premenopausal <i>BRCA1</i> Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis.

Cancers·2024
Same author

Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer.

JAMA network open·2024

Area of Science:

  • Oncology
  • Gynecologic Oncology
  • Preventive Medicine

Background:

  • Ovarian cancer screening efficacy remains uncertain.
  • Advances in imaging and biomarker technology are emerging.
  • Existing screening strategies require further evaluation.

Purpose of the Study:

  • To review the current state of ovarian cancer screening.
  • To discuss ongoing large-scale randomized controlled trials.
  • To explore the potential of novel biomarker discovery methods.

Main Methods:

  • Review of current screening tests and technologies (ultrasound, tumor markers).
  • Analysis of ongoing randomized controlled trials assessing mortality reduction.
  • Discussion of serum proteomics for biomarker discovery and validation needs.

Related Experiment Videos

Main Results:

  • Two large randomized controlled trials are underway to determine screening's impact on mortality.
  • Serum proteomics shows promise but needs rigorous validation for clinical use.
  • Current screening approaches and their limitations are being examined.

Conclusions:

  • The definitive efficacy of ovarian cancer screening is yet to be established.
  • Ongoing trials are crucial for understanding screening's impact on survival.
  • Further research and validation are necessary for novel screening biomarkers.